Hackman Jeffrey S. — SEC insider filings
SEC reporting owner CIK 1926254. 18 insider filings on record with FilingPulse; latest filed 2026-11-02.
Transaction summary — filings shown
Covers all 18 filings on record, filed 2022-08-11 to 2026-11-02. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): 3 legs across 2 filings — 62,600 shares, $202,658 total (shares × price as filed).
- Open-market sales (code S, non-derivative): none reported.
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 21.
- Largest priced transaction: purchase of 47,600 shares @ $2.06 ($98,056) in Comera Life Sciences Holdings, Inc., filed 2022-09-12.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| FENNEC PHARMACEUTICALS INC. (FENC) | Chief Executive Officer, Director | 14 | 2 legs · 15,000 sh · $104,602 | — | 18 |
| Comera Life Sciences Holdings, Inc. (CMRA) | See Remarks., Director | 4 | 1 leg · 47,600 sh · $98,056 | — | 3 |
Insider filings — Hackman Jeffrey S.
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-11-02 | 4 | FENNEC PHARMACEUTICALS INC. (FENC) | Grant/award (A): 1,159 @ $0 | EDGAR |
| 2026-10-13 | 4 | FENNEC PHARMACEUTICALS INC. (FENC) | Grant/award (A): 2,224 @ $5.53 | EDGAR |
| 2026-10-01 | 4 | FENNEC PHARMACEUTICALS INC. (FENC) | Grant/award (A): 1,159 @ $0 | EDGAR |
| 2026-08-31 | 4 | FENNEC PHARMACEUTICALS INC. (FENC) | Grant/award (A): 1,159 @ $0 | EDGAR |
| 2026-08-03 | 4 | FENNEC PHARMACEUTICALS INC. (FENC) | Grant/award (A): 1,159 @ $0 | EDGAR |
| 2026-07-01 | 4 | FENNEC PHARMACEUTICALS INC. (FENC) | Grant/award (A): 1,159 @ $0 | EDGAR |
| 2026-06-01 | 4 | FENNEC PHARMACEUTICALS INC. (FENC) | Grant/award (A): 1,159 @ $0 | EDGAR |
| 2026-05-01 | 4 | FENNEC PHARMACEUTICALS INC. (FENC) | Option exercise (M): 1,159 @ $0 | EDGAR |
| 2026-04-02 | 4 | FENNEC PHARMACEUTICALS INC. (FENC) | Option exercise (M): 16,695 @ $0 · Option exercise (M): 1,159 @ $0 · Option exercise (M): 13,943 @ $0 · Grant/award (A): 200,000 (derivative) @ $5.77 | EDGAR |
| 2026-02-19 | 4 | FENNEC PHARMACEUTICALS INC. (FENC) | Option exercise (M): 13,710 @ $0 | EDGAR |
| 2025-05-19 | 4 | FENNEC PHARMACEUTICALS INC. (FENC) | Purchase (P): 1,035 @ $6.75 · Purchase (P): 13,965 @ $6.99 | EDGAR |
| 2025-04-03 | 4/A | FENNEC PHARMACEUTICALS INC. (FENC) | Grant/award (A): 75,000 (derivative) @ $0 · Grant/award (A): 50,000 (derivative) @ $0 | EDGAR |
| 2025-04-03 | 4 | FENNEC PHARMACEUTICALS INC. (FENC) | Grant/award (A): 75,000 (derivative) @ $0 · Grant/award (A): 50,000 (derivative) @ $0 | EDGAR |
| 2024-08-19 | 4 | FENNEC PHARMACEUTICALS INC. (FENC) | Grant/award (A): 400,000 (derivative) @ $5.58 | EDGAR |
| 2023-09-28 | 4 | Comera Life Sciences Holdings, Inc. (CMRA) | Grant/award (A): 600,000 (derivative) @ $0 | EDGAR |
| 2023-02-16 | 4 | Comera Life Sciences Holdings, Inc. (CMRA) | Grant/award (A): 100,000 (derivative) @ $0 | EDGAR |
| 2022-09-12 | 4 | Comera Life Sciences Holdings, Inc. (CMRA) | Purchase (P): 47,600 @ $2.06 | EDGAR |
| 2022-08-11 | 4 | Comera Life Sciences Holdings, Inc. (CMRA) | Grant/award (A): 300,000 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2021-06-04 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1926254 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs